Randomized Phase III Trial of Amrubicin Versus Topotecan As...

Journal of Clinical Oncology 2014 / 12 Vol. 32; Iss. 35

Randomized Phase III Trial of Amrubicin Versus Topotecan As Second-Line Treatment for Patients With Small-Cell Lung Cancer

von Pawel, J., Jotte, R., Spigel, D. R., O'Brien, M. E. R., Socinski, M. A., Mezger, J., Steins, M., Bosquee, L., Bubis, J., Nackaerts, K., Trigo, J. M., Clingan, P., Schutte, W., Lorigan, P., Reck, M
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
32
Language:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/JCO.2013.54.5392
Date:
December, 2014
File:
PDF, 273 KB
english, 2014
Conversion to is in progress
Conversion to is failed